Literature DB >> 26565974

Association of Big Endothelin-1 with Coronary Artery Calcification.

Ping Qing1, Xiao-Lin Li1, Yan Zhang1, Yi-Lin Li2, Rui-Xia Xu1, Yuan-Lin Guo1, Sha Li1, Na-Qiong Wu1, Jian-Jun Li1.   

Abstract

BACKGROUND: The coronary artery calcification (CAC) is clinically considered as one of the important predictors of atherosclerosis. Several studies have confirmed that endothelin-1(ET-1) plays an important role in the process of atherosclerosis formation. The aim of this study was to investigate whether big ET-1 is associated with CAC. METHODS AND
RESULTS: A total of 510 consecutively admitted patients from February 2011 to May 2012 in Fu Wai Hospital were analyzed. All patients had received coronary computed tomography angiography and then divided into two groups based on the results of coronary artery calcium score (CACS). The clinical characteristics including traditional and calcification-related risk factors were collected and plasma big ET-1 level was measured by ELISA. Patients with CAC had significantly elevated big ET-1 level compared with those without CAC (0.5 ± 0.4 vs. 0.2 ± 0.2, P<0.001). In the multivariate analysis, big ET-1 (Tertile 2, HR = 3.09, 95% CI 1.66-5.74, P <0.001, Tertile3 HR = 10.42, 95% CI 3.62-29.99, P<0.001) appeared as an independent predictive factor of the presence of CAC. There was a positive correlation of the big ET-1 level with CACS (r = 0.567, p<0.001). The 10-year Framingham risk (%) was higher in the group with CACS>0 and the highest tertile of big ET-1 (P<0.01). The area under the receiver operating characteristic curve for the big ET-1 level in predicting CAC was 0.83 (95% CI 0.79-0.87, p<0.001), with a sensitivity of 70.6% and specificity of 87.7%.
CONCLUSIONS: The data firstly demonstrated that the plasma big ET-1 level was a valuable independent predictor for CAC in our study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26565974      PMCID: PMC4643989          DOI: 10.1371/journal.pone.0142458

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  40 in total

1.  Effects of cerebrovascular challenges on plasma endothelin.

Authors:  Wolfgang Jordan; Michael Decker; Heike Kamrowski; Edgar Brunner; Hannelore Ehrenreich; Göran Hajak
Journal:  Neurosci Res       Date:  2002-06       Impact factor: 3.304

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group.

Authors:  L Wexler; B Brundage; J Crouse; R Detrano; V Fuster; J Maddahi; J Rumberger; W Stanford; R White; K Taubert
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

4.  Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation.

Authors:  G C Mautner; S L Mautner; J Froehlich; I M Feuerstein; M A Proschan; W C Roberts; J L Doppman
Journal:  Radiology       Date:  1994-09       Impact factor: 11.105

5.  Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells.

Authors:  M Cattaruzza; C Dimigen; H Ehrenreich; M Hecker
Journal:  FASEB J       Date:  2000-05       Impact factor: 5.191

6.  Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis.

Authors:  C Ihling; T Szombathy; B Bohrmann; M Brockhaus; H E Schaefer; B M Loeffler
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

Review 7.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology.

Authors:  G Sangiorgi; J A Rumberger; A Severson; W D Edwards; J Gregoire; L A Fitzpatrick; R S Schwartz
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension.

Authors:  Huy Hao Dao; Rachida Essalihi; Jean-François Graillon; Richard Larivière; Jacques De Champlain; Pierre Moreau
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

10.  Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells.

Authors:  Sheng Ying Wu; Bao Hong Zhang; Chun Shui Pan; Hong Feng Jiang; Yong Zheng Pang; Chao Shu Tang; Yong Fen Qi
Journal:  Peptides       Date:  2003-08       Impact factor: 3.750

View more
  3 in total

Review 1.  Diabetes and Hypertension Consistently Predict the Presence and Extent of Coronary Artery Calcification in Symptomatic Patients: A Systematic Review and Meta-Analysis.

Authors:  Rachel Nicoll; Ying Zhao; Pranvera Ibrahimi; Gunilla Olivecrona; Michael Henein
Journal:  Int J Mol Sci       Date:  2016-09-06       Impact factor: 5.923

2.  Is endothelin gene polymorphism associated with postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting?

Authors:  Ira Dhawan; Minati Choudhury; Milind P Hote; Anushree Gupta; Poonam Malhotra; Kalaivani V Mani
Journal:  Ann Card Anaesth       Date:  2017 Jul-Sep

Review 3.  Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Authors:  Nikolas Rapp; Pieter Evenepoel; Peter Stenvinkel; Leon Schurgers
Journal:  Toxins (Basel)       Date:  2020-09-29       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.